SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Buch, Maya [2 ]
Combe, Bernard [3 ]
Bessette, Louis [4 ]
Song, In-Ho [5 ]
Song, Yanna [5 ]
Suboticki, Jessica [5 ]
Nash, Peter [6 ]
机构：
[1] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[2] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Manchester, Lancs, England
[3] Univ Montpellier, Montpellier, France
[4] Laval Univ, Quebec City, PQ, Canada
[5] AbbVie Inc, Chicago, IL USA
[6] Griffith Univ, Brisbane, Qld, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P106
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [21] RETENTION OF TOCILIZUMAB AS MONOTHERAPY VERSUS TNF INHIBITORS WITH CONVENTIONAL SYNTHETIC DMARDS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNF INHIBITORS: A STUDY FROM THE TOCERRA COLLABORATION
    Lauper, K.
    Nordstrom, D. C.
    Pavelka, K.
    Hernandez, V.
    Santos, M. J.
    Rotar, Z.
    Iannone, F.
    Codreanu, C.
    Lukina, G.
    Gale, S. L.
    Sarsour, K.
    Pethoe-Schramm, A.
    Courvoisier, D. S.
    Gabay, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 850 - 851
  • [22] Rapid Response With Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A.
    SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
  • [23] Rapid Response with Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
    FitzGerald, Oliver
    Rubbert-Roth, Andrea
    Chen, Kun
    Meenwein, Sebastian
    Enejosa, Jose Jeffrey
    Shaw, Tim
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S53 - S53
  • [25] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 981 - 981
  • [26] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    RHEUMATOLOGY, 2019, 58 : 65 - 65
  • [27] Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy
    Zeng, Xiaofeng
    Zhao, Dongbao
    Radominski, Sebastiao C.
    Keiserman, Mauro
    Lee, Chang K.
    Meerwein, Sebastian
    Enejosa, Jeffrey
    Sui, Yunxia
    Mohamed, Mohamed-Eslam F.
    Park, Won
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1530 - 1539
  • [28] TOCILIZUMAB IMPROVES SYSTEMIC SYMPTOMS OF RHEUMATOID ARTHRITIS IN PATIENTS WITH AN INADEQUATE RESPONSE TO DMARDs
    Bonfiglioli, R.
    Smolen, J.
    Kissel, K.
    Cocco, Maldonado J.
    Ramos-Remus, C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S32 - S32
  • [29] Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs - a systematic review and network meta-analysis
    Jansen, Jeroen P.
    Buckley, Felicity
    Dejonckheere, Fred
    Ogale, Sarika
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [30] Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis
    Jeroen P Jansen
    Felicity Buckley
    Fred Dejonckheere
    Sarika Ogale
    Health and Quality of Life Outcomes, 12
12345